Neither BioPortfolio nor any officer or employee of BioPortfolio Limited, nor Garren Publishing, or any officer or employee of Garren Publishing, accepts any liability whatsoever for any direct, indirect, special or consequential damages or loss arising from any use of this report or their contents, the Biotech Insight Newsletter or Email Alert Service. Changes in rates of currency exchange may have an adverse effect on the value, price or income of investments. Statements as to past performance of any investment are not a guide to future performance. The levels and bases of taxation can change, and if you are in doubt you should seek independent professional advice. In some cases it may be difficult for you to sell or realize your investment or to obtain reliable information about its value or the extent of the risks to which you are exposed.
Biotech stocks are inherently risky.
The opinions expressed in this newsletter are that of the publisher and do not represent a recommendation to buy or sell. The publisher and its associates or employees may have positions in, and from time to time may buy or sell stock mentioned herein. The content of the newsletter reflects information gathered from reliable sources but the accuracy and completeness cannot be guaranteed. All Rights Reserved. No portion of this letter may be reproduced without the written consent of Garren publishing.